Fellowship Objectives

To Learn the Evaluation Process of Potential Lung Transplant Candidates Evaluation of Potential Lung Transplant Candidates Types of advanced lung diseases for which transplantation is an option Indications for bilateral vs. single vs. heart-lung transplant Indications for transplantation Contraindications to transplantation Evaluation of the Potential Lung Donor and Observation of Organ Recovery at a Donor Hospital Observation of Lung Transplant Surgery Bronchoscopy of Lung Transplant Recipients and Management of Post Transplant Airway Complications In-House Management of Lung Transplant Recipients in the Peri-Operative Period Ventilator management of lung recipients ECMO management Hemodynamic management of lung recipients Infectious disease prophylaxis Diagnosis and management of acute allograft rejection Immunosuppression Outpatient Management of Lung Transplant Recipients Outpatient monitoring of the lung allograft, inlcluding evaluation for acute cellular and antibody-mediated rejection Diagnosis and management of acute allograft rejection including histopathological evaluation and grading PFT interpretation in lung recipients Outpatient immunosuppression management Recognition and management of long-term complications including chronic rejection To Gain Enough Experience in Above to Earn UNOS Certification Primary and follow up care of at least 15 newly transplanted lung recipients (documented in a log with the date of transplant and patient’s UNOS number/EPIC MRN; the log must be signed off by the director of the training program) Participate in the evaluation, the donation process and management of 3 multiple organ donors (who are donating a lung or heart/lung) (documented in a log) Observe at least 3 lung or heart/lung procurements (documented in a log with a date that includes the date of procurement, location of the donor and UNOS donor ID) Observe at least 3 lung transplants Management of Patients with Pulmonary Hypertension Assessment and work-up of patients with pulmonary hypertension Indications for the various available therapies and appropriate indications and use of the available oral therapies Initiation and ongoing management of patients with continuous intravenous epoprostenol, treprostinil, SQ treprostinil and inhaled therapies Observe/participate in performance of RHCs (maintain precedures in a log) Experience in reading PH ECHOs Participation in the monthly PH conference Diagnosis and Management of Patients with Interstitial Lung Disease Participation in the multidisciplinary pathology conference Assessment and work up of various ILD diseases Initiation and ongoing management of patients on immunosuppresive and anti-fibrotic therapy Diagnosis and Management of Patients with Cystic Fibrosis and Non-CF Bronchiectasis Indication for genetic therapy Treatment of chronic disease (both pulmonary and extra-pulmonary manifestations) Management of acute exacerbation in the inpatient and outpatient setting